HIMCH
RPRX icon

Hartford Investment Management Co (HIMCO)’s Royalty Pharma RPRX Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,787
Closed -$715K – 546
2022
Q3 		$715K Buy
17,787
+3,867
+28% +$165K 0.02% 485
2022
Q2 		$585K Hold
13,920
– – 0.02% 495
2022
Q1 		$542K Buy
+13,920
New +$547K 0.01% 510

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s RPRX Position: Q4 2022 in Review

Hartford Investment Management Co (HIMCO) sold out of Royalty Pharma (RPRX) in Q4 2022, closing a stake of 17,787 shares — an estimated $715K sold.

Hartford Investment Management Co (HIMCO) first reported a position in RPRX in Q1 2022 and held it in 3 quarters. The position peaked at $715K in Q3 2022. 336 funds tracked by Wall St. Rank hold RPRX as of Q4 2022.

  • Hartford Investment Management Co (HIMCO) reported no remaining Royalty Pharma position as of Q4 2022 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 17,787 Royalty Pharma shares in Q4 2022, an estimated $715K.
  • Hartford Investment Management Co (HIMCO) first reported a position in Royalty Pharma in Q1 2022 and held it in 3 quarters.
  • Hartford Investment Management Co (HIMCO)'s Royalty Pharma position peaked at $715K in Q3 2022.
  • 336 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2022.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q4 2022, filed 20 Jan 2023.